Literature DB >> 22399302

Regulation of karyopherin α1 and nuclear import by mammalian target of rapamycin.

Jill A Fielhaber1, Jason Tan, Kwang-Bo Joung, Ortal Attias, Stefanie Huegel, Michael Bader, Philippe P Roux, Arnold S Kristof.   

Abstract

Under conditions of reduced mitogen or nutritional substrate levels, the serine/threonine kinase target of rapamycin can augment the nuclear content of distinct transcription factors and promote the induction of stress response genes. In its latent (i.e., unphosphorylated) form, the transcription factor STAT1 regulates a subset of genes involved in immune modulation and apoptosis. Based on previous work indicating a functional relationship between mammalian target of rapamycin (mTOR) and the nuclear content of latent STAT1, we investigated the mechanism by which mTOR controls STAT1 nuclear import. By fluorescence confocal microscopy, inactivation of mTOR with rapamycin promoted the nuclear translocation of unphosphorylated STAT1, but not that of a STAT1 mutant incapable of binding its nuclear import adaptor karyopherin-α1 (KPNA1). By immunoprecipitation, KPNA1 was physically associated with mTOR and STAT1 in a complex that translocated to the nucleus in response to rapamycin. Although mTOR is not a kinase for KPNA1, the mTOR-associated phosphatase protein phosphatase 2A catalytic interacted directly with KPNA1 and regulated nuclear import of the mTOR-KPNA1 complex. KPNA1, or its interaction with STAT1, was required for the nuclear import of latent STAT1, transcriptional induction of the STAT1 gene, and caspase-3 activation under conditions of reduced mTOR activity (i.e. rapamycin, glucose starvation, serum withdrawal). Therefore, at low mitogen or nutrient levels, mTOR and protein phosphatase 2A catalytically control the constitutive nuclear import of latent STAT1 by KPNA1, which are key modulators of STAT1 expression and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22399302      PMCID: PMC3340278          DOI: 10.1074/jbc.M111.246785

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

Review 1.  Toll-like receptor signalling.

Authors:  Shizuo Akira; Kiyoshi Takeda
Journal:  Nat Rev Immunol       Date:  2004-07       Impact factor: 53.106

Review 2.  Importin alpha: a multipurpose nuclear-transport receptor.

Authors:  David S Goldfarb; Anita H Corbett; D Adam Mason; Michelle T Harreman; Stephen A Adam
Journal:  Trends Cell Biol       Date:  2004-09       Impact factor: 20.808

3.  Predominant nuclear localization of mammalian target of rapamycin in normal and malignant cells in culture.

Authors:  Xiongwen Zhang; Lili Shu; Hajime Hosoi; K Gopal Murti; Peter J Houghton
Journal:  J Biol Chem       Date:  2002-05-08       Impact factor: 5.157

4.  Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton.

Authors:  D D Sarbassov; Siraj M Ali; Do-Hyung Kim; David A Guertin; Robert R Latek; Hediye Erdjument-Bromage; Paul Tempst; David M Sabatini
Journal:  Curr Biol       Date:  2004-07-27       Impact factor: 10.834

5.  Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein.

Authors:  K Shuai; C Schindler; V R Prezioso; J E Darnell
Journal:  Science       Date:  1992-12-11       Impact factor: 47.728

Review 6.  STAT-1: a novel regulator of apoptosis.

Authors:  Anastasis Stephanou; David S Latchman
Journal:  Int J Exp Pathol       Date:  2003-12       Impact factor: 1.925

7.  mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery.

Authors:  Do-Hyung Kim; D D Sarbassov; Siraj M Ali; Jessie E King; Robert R Latek; Hediye Erdjument-Bromage; Paul Tempst; David M Sabatini
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

8.  Stimulation of signal transducer and activator of transcription-1 (STAT1)-dependent gene transcription by lipopolysaccharide and interferon-gamma is regulated by mammalian target of rapamycin.

Authors:  Arnold S Kristof; Joanna Marks-Konczalik; Eric Billings; Joel Moss
Journal:  J Biol Chem       Date:  2003-06-14       Impact factor: 5.157

9.  High-frequency mutagenesis of human cells and characterization of a mutant unresponsive to both alpha and gamma interferons.

Authors:  R McKendry; J John; D Flavell; M Müller; I M Kerr; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

10.  Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-alpha and -gamma signal transduction pathways.

Authors:  M Müller; C Laxton; J Briscoe; C Schindler; T Improta; J E Darnell; G R Stark; I M Kerr
Journal:  EMBO J       Date:  1993-11       Impact factor: 11.598

View more
  10 in total

1.  Importin-α7 Is Involved in the Formation of Ebola Virus Inclusion Bodies but Is Not Essential for Pathogenicity in Mice.

Authors:  Gülsah Gabriel; Friederike Feldmann; Rudolph Reimer; Swantje Thiele; Meike Fischer; Enno Hartmann; Michael Bader; Hideki Ebihara; Thomas Hoenen; Heinz Feldmann
Journal:  J Infect Dis       Date:  2015-07-16       Impact factor: 5.226

2.  Regulation of ULK1 Expression and Autophagy by STAT1.

Authors:  Alexander A Goldberg; Bernard Nkengfac; Anthony M J Sanchez; Nikolay Moroz; Salman T Qureshi; Antonis E Koromilas; Shuo Wang; Yan Burelle; Sabah N Hussain; Arnold S Kristof
Journal:  J Biol Chem       Date:  2016-12-23       Impact factor: 5.157

3.  Pharmacokinetics of posaconazole within epithelial cells and fungi: insights into potential mechanisms of action during treatment and prophylaxis.

Authors:  Paolo Campoli; David S Perlin; Arnold S Kristof; Theodore C White; Scott G Filler; Donald C Sheppard
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

4.  Identification of importin α 7 specific transport cargoes using a proteomic screening approach.

Authors:  Stefanie Hügel; Reinhard Depping; Gunnar Dittmar; Franziska Rother; Ryan Cabot; Matthias D Sury; Enno Hartmann; Michael Bader
Journal:  Mol Cell Proteomics       Date:  2014-03-12       Impact factor: 5.911

5.  STAT1 gain-of-function heterozygous cell models reveal diverse interferon-signature gene transcriptional responses.

Authors:  Ori Scott; Kyle Lindsay; Steven Erwood; Antonio Mollica; Chaim M Roifman; Ronald D Cohn; Evgueni A Ivakine
Journal:  NPJ Genom Med       Date:  2021-05-14       Impact factor: 8.617

6.  Regulation of protein kinase Cδ Nuclear Import and Apoptosis by Mechanistic Target of Rapamycin Complex-1.

Authors:  Antonio Layoun; Alexander A Goldberg; Ayesha Baig; Mikaela Eng; Ortal Attias; Kristoff Nelson; Alexandra Carella; Nahomi Amberber; Jill A Fielhaber; Kwang-Bo Joung; T Martin Schmeing; Yingshan Han; Jeffrey Downey; Maziar Divangahi; Philippe P Roux; Arnold S Kristof
Journal:  Sci Rep       Date:  2019-11-26       Impact factor: 4.379

7.  Variable Effects of PD-Risk Associated SNPs and Variants in Parkinsonism-Associated Genes on Disease Phenotype in a Community-Based Cohort.

Authors:  Katerina Markopoulou; Bruce A Chase; Ashvini P Premkumar; Bernadette Schoneburg; Ninith Kartha; Jun Wei; Hongjie Yu; Alexander Epshteyn; Lisette Garduno; Anna Pham; Rosa Vazquez; Roberta Frigerio; Demetrius Maraganore
Journal:  Front Neurol       Date:  2021-04-14       Impact factor: 4.003

8.  SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis.

Authors:  Ji-Seung Yoo; Michihito Sasaki; Steven X Cho; Yusuke Kasuga; Baohui Zhu; Ryota Ouda; Yasuko Orba; Paul de Figueiredo; Hirofumi Sawa; Koichi S Kobayashi
Journal:  Nat Commun       Date:  2021-11-15       Impact factor: 14.919

9.  mTOR regulates proteasomal degradation and Dp1/E2F1- mediated transcription of KPNA2 in lung cancer cells.

Authors:  Chun-I Wang; Yan-Yu Chen; Chih-Liang Wang; Jau-Song Yu; Yu-Sun Chang; Chia-Jung Yu
Journal:  Oncotarget       Date:  2016-05-03

10.  Oncogenic effects of urotensin-II in cells lacking tuberous sclerosis complex-2.

Authors:  Alexander A Goldberg; Kwang-Bo Joung; Asma Mansuri; Yujin Kang; Raquel Echavarria; Ljiljana Nikolajev; Yang Sun; Jane J Yu; Stephane A Laporte; Adel Schwertani; Arnold S Kristof
Journal:  Oncotarget       Date:  2016-09-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.